We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.69B
AUM Growth
-$187M
Cap. Flow
-$186M
Cap. Flow %
-11.04%
Top 10 Hldgs %
22.67%
Holding
154
New
18
Increased
32
Reduced
44
Closed
32

Top Buys

Rank Stock Value
1
DOX icon
Amdocs
DOX
+$36M
2
PG icon
Procter & Gamble
PG
+$24.9M
3
GLW icon
Corning
GLW
+$18.7M
4
CARR icon
Carrier Global
CARR
+$17.4M
5
DD icon
DuPont de Nemours
DD
+$17.2M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$36.2M
2
MET icon
MetLife
MET
+$32.7M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$30.6M
4
PAYX icon
Paychex
PAYX
+$27.6M
5
ADM icon
Archer Daniels Midland
ADM
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 16.45%
2 Technology 14.49%
3 Financials 13.6%
4 Industrials 10.79%
5 Consumer Staples 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AJG icon
1
Arthur J. Gallagher & Co
AJG
$63.7B
$47.9M 2.84%
250,380
– –
MCD icon
2
McDonald's
MCD
$188B
$41.9M 2.48%
150,000
+33,980
+29% +$9.1M
NEE icon
3
NextEra Energy
NEE
$187B
$39.4M 2.33%
511,300
+8,700
+2% +$669K
JPM icon
4
JPMorgan Chase
JPM
$939B
$37.8M 2.24%
289,880
-29,580
-9% -$4.05M
MSFT icon
5
Microsoft
MSFT
$2.84T
$37.4M 2.22%
129,830
– –
DOX icon
6
Amdocs
DOX
$5.53B
$37.4M 2.21%
+389,000
New +$36M
LLY icon
7
Eli Lilly
LLY
$1.07T
$36.2M 2.14%
105,330
-14,570
-12% -$4.91M
XOM icon
8
ExxonMobil
XOM
$651B
$35.7M 2.12%
325,950
+100,100
+44% +$11.1M
CB icon
9
Chubb
CB
$140B
$34.6M 2.05%
178,170
+5,000
+3% +$1.05M
UNH icon
10
UnitedHealth
UNH
$382B
$34.5M 2.04%
72,930
-22,280
-23% -$10.8M
AAPL icon
11
Apple
AAPL
$4.89T
$31.1M 1.84%
188,350
-58,600
-24% -$8.65M
MS icon
12
Morgan Stanley
MS
$337B
$28.8M 1.71%
328,200
+55,300
+20% +$5.16M
CVX icon
13
Chevron
CVX
$388B
$28.6M 1.69%
175,110
+110
+0.1% +$18.4K
UPS icon
14
United Parcel Service
UPS
$97.6B
$28.1M 1.67%
145,110
– –
AVGO icon
15
Broadcom
AVGO
$1.82T
$27.5M 1.63%
429,100
+7,800
+2% +$469K
PLD icon
16
Prologis
PLD
$138B
$27.5M 1.63%
220,400
+34,700
+19% +$4.26M
PEP icon
17
PepsiCo
PEP
$186B
$27.5M 1.63%
150,700
-19,600
-12% -$3.43M
SPY icon
18
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$26.2M 1.55%
64,082
-11,115
-15% -$4.43M
KO icon
19
Coca-Cola
KO
$354B
$26.2M 1.55%
422,660
-50,650
-11% -$3.07M
PG icon
20
Procter & Gamble
PG
$343B
$25.9M 1.53%
+174,200
New +$24.9M
MRK icon
21
Merck
MRK
$324B
$25.5M 1.51%
239,800
-98,210
-29% -$10.6M
CMCSA icon
22
Comcast
CMCSA
$79.1B
$25.3M 1.5%
667,570
+303,570
+83% +$11.5M
TXN icon
23
Texas Instruments
TXN
$255B
$25.3M 1.5%
135,880
-24,070
-15% -$4.23M
JCI icon
24
Johnson Controls International
JCI
$87.5B
$24.7M 1.46%
409,440
+57,630
+16% +$3.69M
COST icon
25
Costco
COST
$415B
$24.2M 1.43%
48,690
+70
+0.1% +$34.3K
1
2 3 4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q1 2023 Portfolio in Review

As of Q1 2023, Payden & Rygel held 154 positions worth $1.69B, down 10% from $1.88B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Payden & Rygel withdrew a net $186M in Q1 2023, closing 32 positions and reducing 44 holdings. Its most notable exit was Paychex, an estimated $27.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

Against the trend, Payden & Rygel opened a new position in Amdocs worth $37.4M.

  • Payden & Rygel's largest Q1 2023 buy was Amdocs: 389,000 shares worth $37.4M.
  • Payden & Rygel added most to DuPont de Nemours in Q1 2023, an estimated $17.2M increase.
  • Payden & Rygel's biggest Q1 2023 reduction was CVS Health, cutting an estimated $36.2M.
  • Payden & Rygel fully exited Paychex in Q1 2023, selling an estimated $27.6M.
  • Payden & Rygel's ten largest holdings make up 23% of its $1.69B portfolio in Q1 2023.
  • Payden & Rygel opened 18 new positions and closed 32 in Q1 2023.
  • Payden & Rygel's portfolio value fell 10% quarter-over-quarter to $1.69B.

Based on Payden & Rygel's 13F filing for Q1 2023, filed 10 May 2023.